Medtronic, Inc. (MDT): Is This Stock in Your Portfolio? If Not, Then Consider Getting Some

Page 1 of 2

The market gives investors a good number of chances to buy stocks when they are beaten down, and one such opportunity presented itself when medical devices maker Medtronic, Inc. (NYSE:MDT) slipped in February this year. There were concerns about the company’s business slowing down, but its fourth-quarter results, which were released in May, put such doubts to rest.

Medtronic’s huge size and diversification have helped the company overcome challenges, so it is not surprising that shares have continued their steady appreciation so far this year, rising almost 30%. And once you consider the company’s prospects, it won’t be surprising if the stock continues to fly higher.

An important turnaround

Medtronic, Inc. (NYSE:MDT)

For starters, Medtronic, Inc. (NYSE:MDT)’s implantable cardioverter defibrillators (ICD) and pacemakers, which were the primary reason behind the bearishness of analysts on the stock, are back on the growth path. Sales of defibrillators grew 2% in the previous quarter while pacemaker revenue improved 5% (both excluding currency effects) from the year-ago period.

These improvements are really significant, as both these products were struggling but now seem to be growing again as Medtronic, Inc. (NYSE:MDT) gained market share, and more importantly, helped revenue from its Cardiac Rhythm Disease Management (CRDM) business grow 4% (excluding currency effects). This should have come as welcome relief to Medtronic investors as CRDM has struggled of late.

This market share gain in the CRDM doesn’t come as a surprise as Medtronic, Inc. (NYSE:MDT) was well-positioned to gain from the deficiencies in the ICD offering of its competitor, St. Jude Medical, Inc. (NYSE:STJ). St. Jude’s ICD, the Riata, has faced difficult times and was the subject of a recall in late 2011. The leads inside the defibrillator could break out of the insulation from the inside, according to The Wall Street Journal, and this should have played a part in Medtronic’s share gain.

Now, Medtronic, Inc. (NYSE:MDT) is looking to maintain its new-found momentum in ICD by launching new and improved devices, such as the Evera ICD. Evera would be of smaller size, and the company has made an effort to increase patient comfort through it. Such moves should help Medtronic keep its market share intact in this segment.

Growth ahead

Next, Medtronic has been aggressively focusing on emerging markets to drive international growth. The company’s international revenue has grown consistently in a range of 6%-8% for almost three years, and emerging markets have been the primary drivers of this growth. Going forward, the company is confident of keeping its momentum intact as it increases its presence and builds awareness.

Moreover, Medtronic, Inc. (NYSE:MDT) has been making some notable moves of late as far as new products are concerned. Its advanced insulin pump, which can automate delivery of insulin for Type 1 diabetics through a “threshold suspend” feature is being touted as a breakthrough technology. The company has filed for FDA approval of the device and if approved, it would be a big boost for it.

Also, Medtronic recently received the CE mark for its CoreValve device in Europe, which should improve its standing in the competitive heart valve market in Europe. In addition, its Pacific Plus PTA catheter also received the go-ahead from the FDA along with the European CE mark. These product moves should complement Medtronic’s global presence and help its revenue grow going forward.

Risks to consider

However, being a medical devices manufacturer, Medtronic, Inc. (NYSE:MDT) isn’t immune to the perils of the industry. For instance, the company’s spine business has been a mixed performer and a recent revelation that its Infuse bone graft product, which accelerates bone growth after spinal surgery, doesn’t enjoy an advantage over traditional bone graft procedures led to a dip in share price and might lead to a decline in sales of the product.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!